Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
HEДокторантска мрежа2022–2026

MetRaZymes · Metal-containing Radical Enzymes

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2022-10-01 → 2026-09-30
Финансиране от ЕС
2 406 624 €
Участници
26
Схема
HORIZON-TMA-MSCA-DN

Линиите свързват координатора с партньорите.

Накратко на български

Изкуствени метални ензими се разработват за управление на радикални химични реакции, например за модификация на лекарствени съединения. Те помагат за създаването на по-устойчиви процеси в производството на лекарства, химикали и полимери.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Metal-containing Radical Enzymes

The pharmaceutical, chemical, and polymer industries are cornerstones of Europe’s economy. Biocatalysis is a key element in their transition to more sustainable processes and innovative new compounds. Of particular interest are metallo-enzymes, i.e., proteins that host a metal cofactor. They catalyze a multitude of redox and radical reactions. To access reactions that are unknown in nature, artificial metallo-enzymes can be created. They combine the new-to-nature catalytic activity of metal complexes with the selectivity-inducing environment of the active protein site. Biocatalysis of radical processes is at the heart of many biotransformations, including stereoselective synthesis for the production of pharmaceuticals, late-stage functionalization and diversification of pharmaceutical compounds, and the synthesis of polymeric materials. In order to develop novel biocatalytic routes in academia and industry, a highly interdisciplinary skill set is needed that ranges from chemistry to protein engineering and bioprocess engineering. MetRaZymes is a PhD research and training programme across leading European universities that trains the next generation of scientists capable of tackling the design, development, and implementation of novel enzymatic reactions in a holistic approach. It brings together computational bioscientists, bioinorganic and polymer chemists, and bioprocess engineers. Using artificial and repurposed natural metalloenzymes as the focal point, the Doctoral Candidates develop novel biocatalysts by computational and experimental methods for radical reactions of high synthetic value, such as the late-stage modification of pharmaceutical intermediates, regio-selective functionalizations of aromatic groups in drug molecules, radical atom transfer addition reactions to unsaturated double bonds, radical polymerizations, or the synthesis of polymers from renewable monomers. Moreover, processes to produce the novel enzymes on a larger scale and to run the biotransformations in advanced reactors are being developed. To train the Doctoral Candidates in the needs of industrial biotechnology, the consortium includes eight of Europe´s leading pharmaceutical, chemical, and enzymology companies. The Doctoral Candidates benefit from a vast transferable skills training program delivered by five training partners. Highlights include a Nature Masterclass and Wikipedia workshop. Communication partners such as Wikimedia and the Industrial Biotechnology Innovation Centre act as multiplicators for the communication of results. Moreover, the Doctoral Candidates will work with artists who use biology as their way of expression to create an ARTzymes exhibition that will foster the Doctoral Candidates' creativity and result in a unique form of science dialogue with the general public.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The pharmaceutical, chemical and polymer industries are cornerstones of Europe’s economy. A key element for theirtransition to more sustainable processes and to innovative new compounds is biocatalysis.Of particular interest are metallo-enzymes, i.e. proteins that host a metal cofactor. They catalyze a multitude of redox andradical reactions. To access reactions that are unknown in nature, artificial metallo-enzymes can be created. They combinethe new-to-nature catalytic activity of metal complexes with the selectivity-inducing environment of the active protein site.To develop novel biocatalysts, a highly interdisciplinary skill set is needed. MetRaZymes will create a PhD school acrossleading European universities that will train the next generation of scientists capable of tackling the design, development andimplementation of novel enzymatic reactions in a holistic approach. It brings together computational bioscientists,bioinorganic and polymer chemists, and bioprocess engineers. Using artificial and repurposed metalloenzymes as the focalpoint, the ESRs will develop novel biocatalysts for radical reactions of high synthetic value, such as the late stagemodification of pharmaceutical intermediates or the synthesis of polymers from renewable monomers. To train the ESRs inthe needs of industrial biotechnology, the consortium includes eight of Europe´s leading pharmaceutical, chemical andenzymology companies. The ESRs will benefit from a vast transferable skills training program delivered by five trainingpartners. Highlights include a Nature Masterclass and Wikipedia workshop. Communication partners such as Wikimedia andthe Industrial Biotechnology Innovation Centre will act as muliplicators for the communication of results. Moreover, the ESRswill work with artist that use biology as their way of expression to create an ARTzymes exhibition that will foster the ERS´screativity and result in a an unique form of science dialogue with the general public.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз